Kidney and CV Benefits of JARDIANCE® for Patients with CKD - European Medical Journal

Kidney and CV Benefits of JARDIANCE® for Patients with CKD

Nephrology
Download PDF

This content is sponsored by Boehringer Ingelheim International GmbH.

Cardiovascular (CV) death is one of the leading causes of mortality amongst patients with chronic kidney disease (CKD). In this infographic, the benefits of taking JARDIANCE® for reducing risk of CV death are explained.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.